Abiopharma

🔍 Freda Fabrizio (Director)

Company: BlackRock, Inc. (BLK)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 21 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,783.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Common Stock granted to Nonemployee Directors under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, based on $961.71 per share which was the closing price of the stock on March 31, 2026.